Abstract Two clinical phenotypes for citrin deficiency (CD) have been reported. One is adult-onset citrullinemia type II (CTLN2) and another is neonatal intrahepatic cholestasis caused by citrin deficiency (NICCD). A child with CD and who had failure to thrive (FTT) and dyslipidemia as main clinical manifestations is reported here. Both the weight-and length-for-age at 18 months dropped below the 3rd percentile in the corresponding WHO anthropometry percentile charts, while blood biochemical analysis revealed dramatically increased triglyceride and total cholesterol, together with reduced HDL-cholesterol. Inquiries revealed his aversion to rice and fondness for fish since the age of one year, a peculiar habit which could not be corrected. Since the age of two years, the peculiar diet became more obvious, and slightly increased citrulline and threonine levels were detected on blood amino acid analysis. At the age of two years and five months he was suspected to have CD. Since then, he has been fed in accordance with his own food preferences, and FTT improved gradually, with weight-for-age, in particular, recovering beyond the 3rd percentile at three years of age, and dyslipidemia was also ameliorated gradually. SLC25A13 gene analysis revealed a homozygote of 851del4, and CD was thus confirmed. Diet survey at four years and seven months revealed a fondness for high-protein and low-carbohydrate foods, such as seafood, meat, eggs and milk. This child presented with FTT and dyslipidemia as main clinical manifestations and this was a novel CD phenotype different from NICCD and CTLN2.［Chin J Contemp Pediatr, 2009, 11 (5):328-332］
SONG Yuan-Zong,GUO Li,YANG Yan-Ling et al. Failure to thrive and dyslipidemia caused by citrin deficiency: a novel clinical phenotype[J]. 中国当代儿科杂志, 2009, 11(05): 328-332.
SONG Yuan-Zong,GUO Li,YANG Yan-Ling et al. Failure to thrive and dyslipidemia caused by citrin deficiency: a novel clinical phenotype[J]. CJCP, 2009, 11(05): 328-332.
［1］Kobayashi K, Sinasac DS, Iijima M, Boright AP, Begum L, Lee JR, et al. The gene mutated in adult-onset type II citrullinaemia encodes a putative mitochondrial carrier protein［J］. Nat Genet, 1999, 22(2):159-163.
［2］Saheki T, Kobayashi K. Mitochondrial aspartate glutamate carrier (citrin) deficiency as the cause of adult-onset type II citrullinemia (CTLN2) and idiopathic neonatal hepatitis (NICCD) ［J］. J Hum Genet, 2002, 47(7):333-341.
［3］Ohura T, Kobayashi K, Tazawa Y, Abukawa D, Sakamoto O, Tsuchiya S, et al.Clinical pictures of 75 patients with neonatal intrahepatic cholestasis caused by citrin deficiency (NICCD) ［J］. J Inherit Metab Dis, 2007, 30(2):139-144.
［4］Yazaki M, Takei Y, Kobayashi K, Saheki T, Ikeda S. Risk of worsened encephalopathy after intravenous glycerol therapy in patients with adultonset type II citrullinemia (CTLN2) ［J］. Intern Med, 2005, 44(3):188-195.
［7］Kobayashi K, Shaheen N, Kumashiro R, Tanikawa K, O′Brien WE, Beaudet AL, et al. A search for the primary abnormality in adult-onset type II citrullinemia［J］. Am J Hum Genet, 1993, 53(5):1024-1030.
［8］Shigematsu Y, Hirano S, Hata I, Tanaka Y, Sudo M, Sakura N, et al. Newborn mass screening and selective screening using electrospray tandem mass sprctrometry in Japan［J］. J Chromatogr B, 2002, 776(1):39-48.
［9］Yamaguchi N, Kobayashi K, Yasuda T, Nishi I, Iijima M, Nakagawa M, et al. Screening of SLC25A13 mutations in early and late onset patients with citrin deficiency and in the Japanese population: Identification of two novel mutations and establishment of multiple DNA diagnosis methods for nine mutations［J］. Hum Mutat, 2002, 19(2):122-130.
［11］Olsen EM, Petersen J, Skovgaard AM, Weile B, Jorgensen T, Wright CM. Failure to thrive: the prevalence and concurrence of anthropometric criteria in a general infant population［J］. Arch Dis Child, 2007, 92(2):109-114.
［12］Saheki T, Kobayashi K, Iijima M, Nishi I, Yasuda T, Yamaguchi N, et al. Pathogenesis and pathophysiology of citrin (a mitochondrial aspartate glutamate carrier) deficiency［J］. Metab Brain Dis, 2002, 17(4):335-346.
［13］Saheki T, Kobayashi K, Terashi M, Ohura T, Yanagawa Y, Okano Y, et al. Reduced carbohydrate intake in citrin-deficient subjects［J］. J Inherit Metab Dis, 2008, 31(3):386-394.
［14］Saheki T, Kobayashi K, Iijima M, Moriyama M, Yazaki M, Takei Y,et al. Metabolic derangements in deficiency of citrin, a liver-type mitochondrial aspartate-glutamate carrier［J］. Hepatol Res, 2005, 33(2):181-184.
［15］Saheki T, Kobayashi K, Iijima M, Horiuchi M, Begum L, Jalil MA, et al. Adult-onset type II citrullinemia and idiopathic neonatal hepatitis caused by citrin deficiency: involvement of the aspartate glutamate carrier for urea synthesis and maintenance of the urea cycle［J］. Mol Genet Metab, 2004, 81(Suppl 1):S20-S26.
［16］Dimmock D, Kobayashi K, Iijima M, Tabata A, Wong LJ, Saheki T, et al. Citrin deficiency: a novel cause of failure to thrive that responds to a high-protein, low-carbohydrate diet［J］. Pediatrics, 2007, 119(3):e773-777.
［17］Dimmock D, Maranda B, Dionisi-Vici C, Wang J, Kleppe S, Fiermonte G, et al. Citrin deficiency, a perplexing global disorder［J］. Mol Genet Metab, 2009, 96(1):44-49.
［18］Takahashi H, Kagawa T, Kobayashi K, Hirabayashi H, Yui M, Begum L, et al. A case of adult-onset type II citrullinemia-deterioration of clinical course after infusion of hyperosmotic and high sugar solutions［J］. Med Sci Monit, 2006, 12(2):CS13-15.
［19］Yazaki M, Takei Y, Kobayashi K, Saheki T, Ikeda S. Risk of worsened encephalopathy after intravenous glycerol therapy in patients with adultonset type II citrullinemia (CTLN2)［J］. Intern Med, 2005, 44(3):188-195.
［20］Song YZ, Li BX, Chen FP, Liu SR, Sheng JS, Ushikai M, et al. Neonatal intrahepatic cholestasis caused by citrin deficiency: clinical and laboratory investigation of 13 subjects in mainland of China［J］. Dig Liver Dis, 2009, Epub ahead of print.
［21］Tsai CW, Yang CC, Chen HL, Hwu WL, Wu MZ, Liu KL, et al. Homozygous SLC25A13 mutation in a Taiwanese patient with adult-onset citrullinemia complicated with steatosis and hepatocellular carcinoma［J］. J Formos Med Assoc, 2006, 105(10):852-856.
［22］Soeda J, Yazaki M, Nakata T, Miwa S, Ikeda S, Hosoda W, et al. Primary liver carcinoma exhibiting dual hepatocellular-biliary epithelial differentiations associated with citrin deficiency: a case report［J］. J Clin Gastroenterol, 2008, 42(7):855-860.
［23］Lu YB, Kobayashi K, Ushikai M, Tabata A, Iijima M, Li MX, et al. Frequency and distribution in East Asia of 12 mutations identified in the SLC25A13 gene of Japanese patients with citrin deficiency［J］. J Hum Genet, 2005, 50(7):338-346.
